OVA1Plus® Risk Assessment for Ovarian Cancer

Ovarian cancer constituted 1.1% of new cancer cases in 2021 and is the 4th leading cause of cancer death in women; however, only 20% of ovarian cancers are found at an early stage1. One of the largest challenges with ovarian cancer is that it…

September is National Ovarian Cancer Awareness Month

September is National Ovarian Cancer Awareness month and an important time to raise awareness of the most deadly gynecological cancer in the U.S.  Early signs and symptoms of ovarian cancer are often missed, leading to most ovarian cancers…

Spinal Muscular Atrophy (SMA) Awareness Month

Spinal muscular atrophy (SMA) affects 1 per 8,000 to 10,000 people around the world, according to the National Library of Medicine.1 For SMA Awareness Month, we’re bringing attention to this genetic disorder by highlighting information about…

Check In on Your Skin for UV Safety Month

July is UV Safety Month – an excellent reminder to protect your skin from ultraviolet (UV) rays that can cause skin cancer.1 Sun safety is important year-round, but it’s especially essential in the summer when UV rays reach peak strength…

Matters of Men’s Health and the Importance of Screening

June is Men’s Health Month – what better time to draw attention to men’s unique risks for certain conditions, and encourage men to stay on top of their health. Leading Health Concerns for Men While many of the top health threats for…

Quitters are Winners on World No Tobacco Day

Tobacco use is a global health concern – responsible for more than 8 million annual deaths, according to the World Health Organization (WHO).1 To help combat this epidemic, the WHO established World No Tobacco Day in 1987 ­–an international…

National Women’s Health Week – Making Your Health a Priority

Mother’s Day kicks off a special health observance each year – National Women’s Health Week. Driven by the U.S. Department of Health and Human Services’ Office on Women’s Health, this annual initiative encourages women of all ages…

GeneDx has been acquired by Sema4

Effective May 2nd, GeneDx, formerly a subsidiary of BioReference, has been acquired by Sema4. We’d like to take a moment to reflect on the work that BioReference and GeneDx have accomplished together - helping hundreds of thousands of…

Meet Our Team: Dr. Wojciech Swat, Director of Cancer Genomics

April 2022 marks an eventful year since Dr. Wojciech Swat started as Director of Cancer Genomics Service at GenPath® Diagnostics, a division of BioReference Laboratories. Dr. Swat had previously trained at several prestigious institutions,…

5 Things to Know About Testicular Cancer

In 2022, it’s estimated that 9,910 new cases of testicular cancer will be diagnosed in the United States, according to the American Cancer Society.1 This April, for Testicular Cancer Awareness Month, we’re highlighting some key information…